Skip to main content

Joseph Schwartz

Stock Analyst at Leerink Partners

Total Price Targets
12
Stocks Covered
10
Sectors
Healthcare
Most Recent
Mar 12, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • QURE+233.3%
    uniQure N.V.
    $35.00 targetMar 2, 2026
  • RARE+180.9%
    Ultragenyx Pharmaceutical Inc.
    $60.00 targetMar 12, 2026
  • FULC+86.3%
    Fulcrum Therapeutics, Inc.
    $12.00 targetMay 23, 2025

Most Bearish

  • SRPT-29.0%
    Sarepta Therapeutics, Inc.
    $10.00 targetJul 19, 2025
  • SRPT-14.6%
    Sarepta Therapeutics, Inc.
    $15.00 targetSep 9, 2025
  • DSGN+56.6%
    Design Therapeutics, Inc.
    $14.00 targetDec 3, 2025

Stocks Covered by Joseph Schwartz

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
RAREUltragenyx Pharmaceutical Inc.$60.00$24.79+142.1%2Mar 12, 2026
QUREuniQure N.V.$35.00$19.21+82.1%1Mar 2, 2026
DSGNDesign Therapeutics, Inc.$14.00$13.29+5.3%1Dec 3, 2025
SRPTSarepta Therapeutics, Inc.$15.00$21.60-30.6%2Sep 9, 2025
FULCFulcrum Therapeutics, Inc.$12.00$7.37+62.9%1May 23, 2025
WVEWave Life Sciences Ltd.$22.00$7.32+200.8%1Oct 16, 2024
EWTXEdgewise Therapeutics, Inc.$42.00$30.63+37.1%1Sep 19, 2024
KALVKalVista Pharmaceuticals, Inc.$20.00$26.66-25.0%1Sep 6, 2024
ANTXAN2 Therapeutics, Inc.$5.00$4.69+6.6%1Jul 3, 2024
SLDBSolid Biosciences Inc.$12.00$7.14+67.9%1Jun 24, 2024

Recent Activity

  • Mar 12, 2026— Set$60.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
  • Mar 2, 2026— Set$35.00price target onQURE(uniQure N.V.)
  • Dec 3, 2025— Set$14.00price target onDSGN(Design Therapeutics, Inc.)
  • Sep 9, 2025— Set$15.00price target onSRPT(Sarepta Therapeutics, Inc.)
  • Jul 19, 2025— Set$10.00price target onSRPT(Sarepta Therapeutics, Inc.)
  • May 23, 2025— Set$12.00price target onFULC(Fulcrum Therapeutics, Inc.)
  • Nov 6, 2024— Set$85.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
  • Oct 16, 2024— Set$22.00price target onWVE(Wave Life Sciences Ltd.)
  • Sep 19, 2024— Set$42.00price target onEWTX(Edgewise Therapeutics, Inc.)
  • Sep 6, 2024— Set$20.00price target onKALV(KalVista Pharmaceuticals, Inc.)
  • Jul 3, 2024— Set$5.00price target onANTX(AN2 Therapeutics, Inc.)
  • Jun 24, 2024— Set$12.00price target onSLDB(Solid Biosciences Inc.)

Frequently Asked Questions

Who is Joseph Schwartz?

Joseph Schwartz is a stock analyst at Leerink Partners covering 10 stocks primarily in Healthcare. They have issued 12 price targets since Jun 24, 2024.

What stocks does Joseph Schwartz cover?

Joseph Schwartz currently covers 10 stocks, including RARE, SRPT, QURE, DSGN, FULC.

What is Joseph Schwartz's latest price target?

Joseph Schwartz's most recent price target was $60.00 on RARE (Ultragenyx Pharmaceutical Inc.), set on Mar 12, 2026.

What is Joseph Schwartz's highest price target?

Joseph Schwartz's highest issued price target is $85.00 on RARE, set on Nov 6, 2024.

Coverage based on publicly published price targets. Not investment advice.